BioCentury
ARTICLE | Distillery Therapeutics

Ophthalmic disease

March 15, 2017 3:33 PM UTC

Mouse studies suggest inhibiting NRL expression in photoreceptors using CRISPR/Cas9 could help treat retinitis pigmentosa. In healthy mice, subretinal injection of CRISPR/Cas9 targeting NRL knocked do...

BCIQ Company Profiles

National Eye Institute